GFA

Gifford Fong Associates Portfolio holdings

AUM $434M
This Quarter Return
+15.77%
1 Year Return
+29.73%
3 Year Return
+147.08%
5 Year Return
+262.06%
10 Year Return
AUM
$431M
AUM Growth
+$431M
Cap. Flow
-$499K
Cap. Flow %
-0.12%
Top 10 Hldgs %
44%
Holding
136
New
4
Increased
2
Reduced
4
Closed

Top Buys

1
SHOP icon
Shopify
SHOP
$7.92M
2
CRM icon
Salesforce
CRM
$7.26M
3
ZM icon
Zoom
ZM
$5.06M
4
BEN icon
Franklin Resources
BEN
$1.55M
5
LUMN icon
Lumen
LUMN
$1.46M

Sector Composition

1 Technology 29.12%
2 Financials 20.88%
3 Communication Services 12.04%
4 Consumer Discretionary 11.21%
5 Healthcare 10.68%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ORCL icon
26
Oracle
ORCL
$628B
$4.46M 1.04%
69,000
EMR icon
27
Emerson Electric
EMR
$72.9B
$4.02M 0.93%
50,000
BA icon
28
Boeing
BA
$176B
$4.01M 0.93%
18,710
X
29
DELISTED
US Steel
X
$3.99M 0.93%
237,700
FHN icon
30
First Horizon
FHN
$11.4B
$3.83M 0.89%
300,000
C icon
31
Citigroup
C
$175B
$3.79M 0.88%
61,471
GE icon
32
GE Aerospace
GE
$293B
$3.63M 0.84%
336,297
META icon
33
Meta Platforms (Facebook)
META
$1.85T
$3.42M 0.79%
12,500
IVZ icon
34
Invesco
IVZ
$9.68B
$3.23M 0.75%
185,393
PBI icon
35
Pitney Bowes
PBI
$2.07B
$3.15M 0.73%
511,059
BEN icon
36
Franklin Resources
BEN
$13.3B
$3.01M 0.7%
120,437
+62,108
+106% +$1.55M
HON icon
37
Honeywell
HON
$136B
$3M 0.7%
14,100
ABBV icon
38
AbbVie
ABBV
$374B
$2.99M 0.69%
27,900
F icon
39
Ford
F
$46.2B
$2.86M 0.66%
325,000
BIIB icon
40
Biogen
BIIB
$20.8B
$2.82M 0.65%
11,500
LLY icon
41
Eli Lilly
LLY
$661B
$2.72M 0.63%
16,100
T icon
42
AT&T
T
$208B
$2.69M 0.63%
93,689
WFC icon
43
Wells Fargo
WFC
$258B
$2.66M 0.62%
88,052
LOW icon
44
Lowe's Companies
LOW
$146B
$2.46M 0.57%
15,320
PNW icon
45
Pinnacle West Capital
PNW
$10.6B
$2.4M 0.56%
30,000
WBA
46
DELISTED
Walgreens Boots Alliance
WBA
$2.39M 0.56%
60,000
BAX icon
47
Baxter International
BAX
$12.1B
$2.33M 0.54%
29,000
SIVB
48
DELISTED
SVB Financial Group
SIVB
$2.33M 0.54%
6,000
SBUX icon
49
Starbucks
SBUX
$99.2B
$2.25M 0.52%
21,000
BMY icon
50
Bristol-Myers Squibb
BMY
$96.7B
$2.23M 0.52%
35,899